treated LN patients and MRL/lpr mice with a combination of mycophenolate mortiate, calcineurin inhibitors, and steroids, resulting in significant inhibition of Caspase-1/GSDMD-mediated pyroptosis and alleviation of disease progression (118). This evidence concerns the gene CASP1 and lobular neoplasia.